June 2026
Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.
Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.
How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.
New ASCO guidelines are designed to make the full body of evidence accessible to clinicians across specialties, including those who may not work routinely with a head and neck surgeon.
Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.
A new study focused on stories will change health outcomes for Black women.
The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.
Cancer resources and compassion are plentiful in a quiet space at Providence Cancer Institute Franz Clinic.
Dr. Kelly Perlewitz answers timely questions about the rise of colon cancer cases in younger adults.
We celebrate the work of oncology social workers, whose work is essential, transformative and deeply human.
Palliative care can help manage pain, fatigue, anxiety and so much more – at any stage of cancer treatment.
Providence Heart Clinic – Newberg recently hosted screenings for kids ages 12–18.
The study may redefine care for many people at the earliest stage of their treatment.
Breastfed babies’ immune systems are better equipped to fight infections and other illnesses. Hear from a caregiver about the program offering lifesaving donor milk to new families in Hood River.
Get to know the women of the Immune Monitoring Laboratory and how their curiosity, tenacity and passion are driving progress in cancer research at Providence Cancer Institute.
Dr. Natasha Edwin advocates for making more quality clinical trials available for patients in rural communities.
A new study aims to move cervical cancer care forward and improve the chance of long-term remission for more patients.
A targeted therapy being evaluated in a clinical trial may improve survival for high-risk patients with diffuse large B-cell lymphoma.
Marge received treatment for pancreatic cancer at Providence Cancer Institute and then volunteered in the infusion center to help the care team that supported her.
Catch the 2025 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.